Literature DB >> 23090955

Role of YopK in Yersinia pseudotuberculosis resistance against polymorphonuclear leukocyte defense.

Sara E Thorslund1, David Ermert, Anna Fahlgren, Saskia F Erttmann, Kristina Nilsson, Ava Hosseinzadeh, Constantin F Urban, Maria Fällman.   

Abstract

The enteropathogen Yersinia pseudotuberculosis can survive in the harsh environment of lymphoid compartments that abounds in immune cells. This capacity is dependent on the plasmid-encoded Yersinia outer proteins (Yops) that are delivered into the host cell via a mechanism involving the Yersinia type III secretion system. We show that the virulence protein YopK has a role in the mechanism by which Y. pseudotuberculosis avoids the polymorphonuclear leukocyte or neutrophil (PMN) defense. A yopK mutant, which is attenuated in the mouse infection model, where it fails to cause systemic infection, was found to colonize Peyer's patches and mesenteric lymph nodes more rapidly than the wild-type strain. Further, in mice lacking PMNs, the yopK mutant caused full disease with systemic spread and typical symptoms. Analyses of effects on PMNs revealed that both the wild-type strain and the yopK mutant inhibited internalization and reactive oxygen species production, as well as neutrophil extracellular trap formation by PMNs. However, the wild-type strain effectively avoided induction of PMN death, whereas the mutant caused a necrosis-like PMN death. Taken together, our results indicate that YopK is required for the ability of Yersinia to resist the PMN defense, which is critical for the virulence of the pathogen. We suggest a mechanism whereby YopK functions to prevent unintended Yop delivery and thereby PMN disruption, resulting in necrosis-like cell death, which would enhance the inflammatory response favoring the host.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23090955      PMCID: PMC3536157          DOI: 10.1128/IAI.00650-12

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  54 in total

Review 1.  Yersiniosis. II: The pathogenesis of Yersinia infections.

Authors:  H J Koornhof; R A Smego; M Nicol
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1999-02       Impact factor: 3.267

Review 2.  Yersinia outer proteins: role in modulation of host cell signaling responses and pathogenesis.

Authors:  Gloria I Viboud; James B Bliska
Journal:  Annu Rev Microbiol       Date:  2005       Impact factor: 15.500

Review 3.  How do microbes evade neutrophil killing?

Authors:  Constantin F Urban; Sebastian Lourido; Arturo Zychlinsky
Journal:  Cell Microbiol       Date:  2006-08-24       Impact factor: 3.715

4.  Measurement of effector protein injection by type III and type IV secretion systems by using a 13-residue phosphorylatable glycogen synthase kinase tag.

Authors:  Julie Torruellas Garcia; Franco Ferracci; Michael W Jackson; Sabrina S Joseph; Isabelle Pattis; Lisa R W Plano; Wolfgang Fischer; Gregory V Plano
Journal:  Infect Immun       Date:  2006-10       Impact factor: 3.441

5.  YopK of Yersinia pseudotuberculosis controls translocation of Yop effectors across the eukaryotic cell membrane.

Authors:  A Holmström; J Petterson; R Rosqvist; S Håkansson; F Tafazoli; M Fällman; K E Magnusson; H Wolf-Watz; A Forsberg
Journal:  Mol Microbiol       Date:  1997-04       Impact factor: 3.501

6.  Invasin-dependent and invasin-independent pathways for translocation of Yersinia pseudotuberculosis across the Peyer's patch intestinal epithelium.

Authors:  A Marra; R R Isberg
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

7.  Yops of Yersinia enterocolitica inhibit receptor-dependent superoxide anion production by human granulocytes.

Authors:  L G Visser; E Seijmonsbergen; P H Nibbering; P J van den Broek; R van Furth
Journal:  Infect Immun       Date:  1999-03       Impact factor: 3.441

8.  The proinflammatory response induced by wild-type Yersinia pseudotuberculosis infection inhibits survival of yop mutants in the gastrointestinal tract and Peyer's patches.

Authors:  Lauren K Logsdon; Joan Mecsas
Journal:  Infect Immun       Date:  2006-03       Impact factor: 3.441

9.  Interaction between the Yersinia protein tyrosine phosphatase YopH and eukaryotic Cas/Fyb is an important virulence mechanism.

Authors:  Fabienne Deleuil; Lena Mogemark; Matthew S Francis; Hans Wolf-Watz; Maria Fällman
Journal:  Cell Microbiol       Date:  2003-01       Impact factor: 3.715

10.  Mesenteric lymph nodes at the center of immune anatomy.

Authors:  Andrew J Macpherson; Karen Smith
Journal:  J Exp Med       Date:  2006-03-13       Impact factor: 14.307

View more
  11 in total

1.  The Tat Substrate SufI Is Critical for the Ability of Yersinia pseudotuberculosis To Cause Systemic Infection.

Authors:  Ummehan Avican; Tugrul Doruk; Yngve Östberg; Anna Fahlgren; Åke Forsberg
Journal:  Infect Immun       Date:  2017-03-23       Impact factor: 3.441

2.  Flagellin-Mediated Protection against Intestinal Yersinia pseudotuberculosis Infection Does Not Require Interleukin-22.

Authors:  Rémi Porte; Laurye Van Maele; Natalia Muñoz-Wolf; Benoit Foligné; Laure Dumoutier; Julien Tabareau; Delphine Cayet; Pierre Gosset; Nicolas Jonckheere; Isabelle Van Seuningen; José A Chabalgoity; Michel Simonet; Mohamed Lamkanfi; Jean-Christophe Renauld; Jean-Claude Sirard; Christophe Carnoy
Journal:  Infect Immun       Date:  2017-01-26       Impact factor: 3.441

Review 3.  Modulation of innate immune responses by Yersinia type III secretion system translocators and effectors.

Authors:  James B Bliska; Xiaoying Wang; Gloria I Viboud; Igor E Brodsky
Journal:  Cell Microbiol       Date:  2013-07-29       Impact factor: 3.715

4.  Yersinia pestis targets neutrophils via complement receptor 3.

Authors:  Peter M Merritt; Thomas Nero; Lesley Bohman; Suleyman Felek; Eric S Krukonis; Melanie M Marketon
Journal:  Cell Microbiol       Date:  2014-11-25       Impact factor: 3.715

5.  Role of the Yersinia YopJ protein in suppressing interleukin-8 secretion by human polymorphonuclear leukocytes.

Authors:  Justin L Spinner; Aaron M Hasenkrug; Jeffrey G Shannon; Scott D Kobayashi; B Joseph Hinnebusch
Journal:  Microbes Infect       Date:  2015-09-08       Impact factor: 2.700

6.  Yersinia pseudotuberculosis efficiently escapes polymorphonuclear neutrophils during early infection.

Authors:  Linda Westermark; Anna Fahlgren; Maria Fällman
Journal:  Infect Immun       Date:  2013-12-30       Impact factor: 3.441

7.  Oral vaccination with live attenuated Yersinia pseudotuberculosis strains delivering a FliC180-LcrV fusion antigen confers protection against pulmonary Y. Pestis infection.

Authors:  Amit K Singh; Xiuran Wang; Wei Sun
Journal:  Vaccine       Date:  2020-04-08       Impact factor: 3.641

8.  A Recombinant Attenuated Yersinia pseudotuberculosis Vaccine Delivering a Y. pestis YopENt138-LcrV Fusion Elicits Broad Protection against Plague and Yersiniosis in Mice.

Authors:  Amit K Singh; Roy Curtiss; Wei Sun
Journal:  Infect Immun       Date:  2019-09-19       Impact factor: 3.609

Review 9.  Unraveling neutrophil- Yersinia interactions during tissue infection.

Authors:  Joan Mecsas
Journal:  F1000Res       Date:  2019-07-11

10.  The cytotoxic necrotizing factor of Yersinia pseudotuberculosis (CNFY) enhances inflammation and Yop delivery during infection by activation of Rho GTPases.

Authors:  Janina Schweer; Devesha Kulkarni; Annika Kochut; Joern Pezoldt; Fabio Pisano; Marina C Pils; Harald Genth; Jochen Huehn; Petra Dersch
Journal:  PLoS Pathog       Date:  2013-11-07       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.